Latest Period
Q2 2026
Security Snapshot
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH Institutional Ownership
CUSIP: 00337E207
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
1
Shares (Excl. Options)
4,783
Price
$247.90
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / NY ARCA BIOTECH
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 4,783
- Total 13F value
- $1,185,707
- Portfolio coverage rank
- 0%
- Share change
- +4,783
- Value change
- +$1,185,707
- Number of holders
- 1
- SEC-reported price per share
- $247.90
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- 00337E207 - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH is tracked under CUSIP 00337E207.
- 1 institution reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 0 to 1 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $0 to $1,185,707.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 1 institution filings for Q2 2026.
Security key
00337E207
Latest holder period
Q2 2026
13F holders
1
13D/G owners
0
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00337E207:
As of 30 Jun 2026, 1 institutional investors reported holding 4,783 shares of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q2 2026
Rows shown
1-5 of 5